Jin Kim Montclare | |
---|---|
Alma mater | Fordham University Yale University |
Known for | Biomolecular engineering |
Awards | AAAS Leshner Fellow (2019) Agnes Fay Morgan Research Award (2015) |
Scientific career | |
Institutions | California Institute of Technology New York University |
Thesis | Specific recognition of DNA by natural transcription factors and miniature protein mimics (2002) |
Jin Kim Montclare is a Professor of Chemical and Biomolecular Engineering at New York University. She creates novel proteins that can be used in drug delivery, tissue regeneration, and medical treatment. She is a 2019 AAAS Leshner Leadership Fellow and has been inducted into the AIMBE College of Fellows.
Montclare was born in The Bronx. She is a first-generation Korean American. [1] She became interested in chemistry in high school. [2] She studied at Fordham University, where she majored in chemistry and minored in philosophy. [3] She earned her bachelor's degree in 1997. [1] She was awarded the Merck Index Award for excellence in organic chemistry and the Clare Boothe Luce Scholarship for women in science. Montclare was elected a member of Iota Sigma Pi. She moved to Yale University for her graduate degree, earning a master's in 2001 and a PhD in 2003. She worked in the lab of Alanna Schepartz, completing a thesis on the recognition of DNA by natural transcription factors. [4] Her graduate research was supported by the National Science Foundation and Pfizer. [4] She attributes her passion for chemistry to her mentors, including her grandmother.
Montclare joined California Institute of Technology as an National Institutes of Health postdoctoral fellow, where she began to work on engineering new molecules with David A. Tirrell. [5] She joined New York University in 2005, where she leads the Protein Engineering and Molecular Design Lab. [6] [7]
Montclare has worked with the United States Department of Defense to detoxify organophosphates, which are commonly used in pesticides and as warfare agents. [8] She develops stable, activate fluorinated phosphotriesterase (PTE) variants by combining PTE with non-canonical amino acids. [9] She has also developed protein-engineered hydrogels that could be used as biomimetic materials. [10] Instead of synthetically creating polymers, Montclare uses biologically engineered proteins that can be easily controlled by external stimuli. [11] Montclare's protein-based hydrogels can be used to direct neuronal growth for brain augmentation. [12] The hydrogels could be used to heal wounds, sense or control the flow of fluids or deliver medicine. [11] They are made from Escherichia coli bacterium which are patterned onto substrates, similar to how geckos can adhere to surfaces. [11] The She has developed a range of other nanomaterials derived from proteins, including coiled-coil fibres and helix-elastin block polymers. [13] [14]
Other research in the Montclare group includes the design of protein-lipid macromolecular systems that can be used to transport nanoparticles, drugs, and genes to treat a variety of medical conditions. [10] The lipoprotoeplexes can be used to deliver drugs and genes across many types of cells in a GeneTrain. [15] They can form complexes with nucleic acid and small hydrophobic drugs. [16] [17] The lipid container permits transfection past a cell membrane, whilst the protein capsule can bind chemotherapeutic molecules. [18]
Montclare has been involved with outreach programs to introduce people in K-12 Education to science studies at the NYU Tandon School of Engineering. [19] She hosts a group of high school students for research opportunities every summer as well as leading outreach programs in Brooklyn high schools. [8] Montclare is part of the National Science Foundation Innovation Corps (I-Corps) program, and since 2013 has directed the New York University Tandon I-Corps site, the Convergence of Innovation and Entrepreneurship (CIE) Institute. [20] [21] [22] At the CIE Montclare seeks to increase the representation of women and underrepresented minority entrepreneurs, with the hope to increase their participation in STEM careers. [20] Whilst only 20% of engineering students in the United States are women, at New York University women make up between 40 and 45%. [23] She has written for The Huffington Post about the need for parents and adults to be more proactive in engaging their children with science. [24] Montclare co-founded inSchoolApps, who make web-based applications for science-based applications. [23] [25] Montclare was featured in the Marvel Comics Unstoppable Wasp. [26]
The New York University Tandon School of Engineering is the engineering and applied sciences school of New York University. Tandon is the second oldest private engineering and technology school in the United States.
A hydrogel is a biphasic material, a mixture of porous and permeable solids and at least 10% of water or other interstitial fluid. The solid phase is a water insoluble three dimensional network of polymers, having absorbed a large amount of water or biological fluids. Hydrogels have several applications, especially in the biomedical area, such as in hydrogel dressing. Many hydrogels are synthetic, but some are derived from natural materials. The term "hydrogel" was coined in 1894.
Poly(N-isopropylacrylamide) (variously abbreviated PNIPA, PNIPAM, PNIPAAm, NIPA, PNIPAA or PNIPAm) is a temperature-responsive polymer that was first synthesized in the 1950s. It can be synthesized from N-isopropylacrylamide which is commercially available. It is synthesized via free-radical polymerization and is readily functionalized making it useful in a variety of applications.
Nicholas (Nikolaos) A. Peppas is a chemical and biomedical engineer whose leadership in biomaterials science and engineering, drug delivery, bionanotechnology, pharmaceutical sciences, chemical and polymer engineering has provided seminal foundations based on the physics and mathematical theories of nanoscale, macromolecular processes and drug/protein transport and has led to numerous biomedical products or devices.
Arginylglycylaspartic acid (RGD) is the most common peptide motif responsible for cell adhesion to the extracellular matrix (ECM), found in species ranging from Drosophila to humans. Cell adhesion proteins called integrins recognize and bind to this sequence, which is found within many matrix proteins, including fibronectin, fibrinogen, vitronectin, osteopontin, and several other adhesive extracellular matrix proteins. The discovery of RGD and elucidation of how RGD binds to integrins has led to the development of a number of drugs and diagnostics, while the peptide itself is used ubiquitously in bioengineering. Depending on the application and the integrin targeted, RGD can be chemically modified or replaced by a similar peptide which promotes cell adhesion.
Smart polymers, stimuli-responsive polymers or functional polymers are high-performance polymers that change according to the environment they are in.
Kristi S. Anseth is the Tisone Distinguished Professor of Chemical and Biological Engineering, an Associate Professor of Surgery, and a Howard Hughes Medical Investigator at the University of Colorado at Boulder. Her main research interests are the design of synthetic biomaterials using hydrogels, tissue engineering, and regenerative medicine.
Jindřich Henry Kopeček was born in Strakonice, Czech Republic, as the son of Jan and Herta Zita (Krombholz) Kopeček. He is distinguished professor of pharmaceutical chemistry and distinguished professor of biomedical engineering at the University of Utah in Salt Lake City, Utah. Kopeček is also an honorary professor at Sichuan University in Chengdu, China. His research focuses on biorecognition of macromolecules, bioconjugate chemistry, drug delivery systems, self-assembled biomaterials, and drug-free macromolecular therapeutics.
Paula Therese Hammond is an Institute Professor and the Vice Provost for Faculty at the Massachusetts Institute of Technology (MIT). She was the first woman and person of color appointed as head of the Chemical Engineering department. Her laboratory designs polymers and nanoparticles for drug delivery and energy-related applications including batteries and fuel cells.
Nanocomposite hydrogels are nanomaterial-filled, hydrated, polymeric networks that exhibit higher elasticity and strength relative to traditionally made hydrogels. A range of natural and synthetic polymers are used to design nanocomposite network. By controlling the interactions between nanoparticles and polymer chains, a range of physical, chemical, and biological properties can be engineered. The combination of organic (polymer) and inorganic (clay) structure gives these hydrogels improved physical, chemical, electrical, biological, and swelling/de-swelling properties that cannot be achieved by either material alone. Inspired by flexible biological tissues, researchers incorporate carbon-based, polymeric, ceramic and/or metallic nanomaterials to give these hydrogels superior characteristics like optical properties and stimulus-sensitivity which can potentially be very helpful to medical and mechanical fields.
Molly S. Shoichet, is a Canadian science professor, specializing in chemistry, biomaterials and biomedical engineering. She was Ontario's first Chief Scientist. Shoichet is a biomedical engineer known for her work in tissue engineering, and is the only person to be a fellow of the three National Academies in Canada.
Antonios Georgios Mikos is a Greek-American biomedical engineer who is the Louis Calder Professor of Bioengineering and Chemical and Biomolecular Engineering at Rice University. He specialises in biomaterials, drug delivery, and tissue engineering.
Joyce Y. Wong is an American engineer who is Professor of Biomedical Engineering and Materials Science and Engineering at Boston University. Her research develops novel biomaterials for the early detection treatment of disease. Wong is the Inaugural Director of the Provost's Initiative to promote gender equality and inclusion in STEM at all levels: Advance, Recruit, Retain and Organize Women in STEM. She is a Fellow of the American Association for the Advancement of Science, American Institute for Medical and Biological Engineering and Biomedical Engineering Society.
Aline Fiona Miller is a Professor of Biomolecular Engineering at the University of Manchester. She specialises in the characterisation of polymer, biopolymer and peptides, using neutron and x-ray scattering, as well as the development of functionalised nanostructures for regenerative medicine and toxicology testing.
Heather D. Maynard is the Dr Myung Ki Hong Professor in Polymer Science at the University of California, Los Angeles. She works on protein-polymer conjugates and polymeric drugs. Maynard is a Fellow of the Royal Society of Chemistry and the American Association for the Advancement of Science.
Kristi Lynn Kiick is the Blue and Gold Distinguished Professor of Materials Science and Engineering at the University of Delaware. She studies polymers, biomaterials and hydrogels for drug delivery and regenerative medicine. She is a Fellow of the American Chemical Society, the American Institute for Medical and Biological Engineering, and of the National Academy of Inventors. She served for nearly eight years as the deputy dean of the college of engineering at the University of Delaware.
André Taylor is an American scientist who is an associate professor of chemical engineering at the New York University Tandon School of Engineering. Taylor works on novel materials for energy conversion and storage. He was awarded the Presidential Early Career Award for Scientists and Engineers in 2010, and named as one of The Community of Scholars' Most Influential Black Researchers of 2020.
Tatiana Segura is an American biomedical engineer who is a professor at Duke University. Her research considers biomedical engineering solutions to promote cell growth. She was elected Fellow of the American Institute for Medical and Biological Engineering in 2017 and awarded the Acta Biomaterialia Silver Medal in 2021.
Bioprinting drug delivery is a method for producing drug delivery vehicles. It uses three-dimensional printing of biomaterials via additive manufacturing. Such vehicles are biocompatible, tissue-specific hydrogels or implantable devices. 3D bioprinting prints cells and biological molecules to form tissues, organs, or biological materials in a scaffold-free manner that mimics living human tissue. The technique allows targeted disease treatments with scalable and complex geometry.
{{cite journal}}
: Cite journal requires |journal=
(help){{cite web}}
: |author=
has generic name (help){{cite journal}}
: Cite journal requires |journal=
(help)